Coagulation Factor IX

Domain Structure of Factor IX
The domain structure of factor IX is represented, where: GLA=region containing γ-carboxyglutamic acid residues, EGF=region containing sequences homologous to human epidermal growth factor, AP=activation peptide released upon conversion of the zymogen to the active serine protease, and CATALYTIC DOMAIN=region containing the serine protease catalytic triad. Arrows indicate the sites which are proteolytically cleaved by factor XIa during activation of the zymogen, with arrow A being cleaved first.

Showing the single result

  • Bovine factor IX

    BCIX-1040

    $59.00 – $510.00

    SKU: BCIX-1040 Category:
    Price:$59.00/100 µg, $510.00/1mg
    Safety Data Sheet
    Size 100 µg, 1mg
    Formulation 50% glycerol/water (v/v)
    Storage -20°C
    Shelf Life 12 months
    Purity >95% by SDS-PAGE
    Activity Determination Clotting assay

The zymogen factor IX is a single chain vitamin K-dependent glycoprotein which is synthesized in the liver (1-3). The domain structure of factor IX is similar to that of the other vitamin K dependent coagulation factors. The NH2-terminal region contains 12 γ-carboxyglutamic acid (gla) residues which facilitate the calcium dependent binding of factor IX to negatively charged phospholipid surfaces. Two domains which are homologous to epidermal growth factor (EGF) span the region between the NH2-terminal gla domain and the activation peptide (Ala-146 to Arg-180).

Factor IX is activated by either factor XIa or the factor VIIa/tissue factor/phospholipid complex. Cleavage at site A (see figure) yields the intermediate IXa which is subsequently converted to the fully active form IXaβ by cleavage at site B. The NH2-terminal light chain (GLA and EGF domains) remains covalently attached to the COOH-terminal heavy chain by a disulfide bond. The serine protease catalytic triad (Ser-365, His 221, Asp-269) is located in the heavy chain. Factor IXaβ is the catalytic component of the “intrinsic factor Xase complex” (factor VIIIa/IXa/Ca2+/phospholipid) which proteolytically activates factor X to factor Xa.

Human factor IX is prepared from fresh frozen plasma by a combination of conventional procedures (4) and immunoaffinity chromatography (5). Bovine factor IX is prepared from fresh citrated bovine plasma by a modification of the method described by Fujikawa et al. (6). The purified proteins are supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20oC. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay.

Sample gel image
GelNovex 4-12% Bis-Tris
LoadHuman Factor IX, 1 µg per lane
BufferMOPS
StandardSeeBluePlus 2; Myosin (191 kDa), Phosphorylase B (97 kDa), BSA (64 kDa), Glutamic Dehydrogenase (51 kDa), Alcohol Dehydrogenase (39 kDa), Carbonic Anhydrase (28 kDa), Myoglobin Red (19 kDa), Lysozyme (14 kDa)
LocalizationPlasma
Plasma concentration4-5 ug/ml (human) (1)
Mode of actionZymogen; precursor to the serine protease factor IXa
Molecular weight55,000 (human) (8)
55,400 (bovine) (6)
Extinction coefficient
E
1 %
1 c m, 280 nm
= 13.2 (human)(7)
  = 12.0 (bovine) (6)
Isoelectric point4.2-4.5 (human) (7)
3.7 (bovine) (6)
Structuresingle chain, NH2-terminal gla-domain, two EGF domains
Percent carbohydrate17% (human) (7)
26% (bovine) (6)
Post-translational modificationsone β-hydroxyaspartate (9), twelve gla residues (7)
  1. Thompson, A.R., Blood, 67, 565 (1986).
  2. Hedner, U., et al., In Hemostasis and Thrombosis, 2nd edition, ed. R.W. Colman, J. Hirsh, V.J. Marder, E.W.
  3. Salzman, pp. 39-47. J.P. Lippincott Co, Philadelphia, 1987.
  4. Fujikawa, K., Davie, EW., Methods in Enzymology, 45, 74 (1976).
  5. Bajaj, S.P., et al., Prep. Biochem., 11, 397 (1981).
  6. Jenny, R.J., et al., Prep. Biochem., 16, 227 (1986).
  7. Fujikawa, K., et al., Biochemistry, 12, 4938 (1973).
  8. Discipio, R.G., et al., Biochemistry, 16, 698 (1977).
  9. Osterud, B., et al., J. Biol. Chem., 253, 5946 (1978).
  10. McMullen, B.A., et al., BBRC, 115, 8 (1983).
  1. Warejcka, D., Biochem. J. (2005) 392, 703–712. (used as an assay standard in a cell proliferation assay)

This publication list is not all encompassing, and is only meant to provide limited examples of how Prolytix products are used. We encourage you to search the literature for other examples pertinent to your experimentation, and to contact us with any technical questions.

Shopping Cart